This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Oncology  • Breast Cancer  • Cervical Cancer  • Oncology, Other  • Dermatology  • Dermatologic Disorders  • Radiation Therapy  • Women's Health  • Women's Health, Other  • Dermatologic Disorders, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Koji Chiyomaru, MD; Chikako Nishigori, MD, PhD

Arch Dermatol. 2009;145(7):841-842.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Acquired lymphangiectasia (AL), previously called acquired lymphangioma, was first described in 1956 by Plotnick and Richfield¹ as a complication of radical mastectomy. Like lymphangiosarcoma, which may arise as a complication of chronic lymphedema,^2-3 AL mainly occurs after surgery and radiation therapy for malignant neoplasms such as breast carcinoma⁴ and uterine carcinoma,⁵ which suggests that these therapies might cause AL. In addition, the period from the preceding illness to the development of AL varies. The present study investigates the relationship between therapy and the onset of AL.

Methods

Seventy-three cases of AL in Japan were investigated. The mean latent period before the appearance of AL was statistically assessed using the Welch t test in relevance to therapies the patients underwent: surgery, irradiation, or both. We also examined the relationship of lymph node dissection (LND) to the development of AL.

Results
The male to female ratio among . . . [Full Text of this Article]

Comment

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?